News

OAGi and NIIMBL Announce Release of Biopharmaceutical Manufacturing Ontologies to Advance Interoperability and Analytics

Biopharmaceutical

The National Institute for Innovation in Manufacturing Biopharmaceuticals (NIIMBL) and the Open Applications Group, Inc. (OAGi) are proud to announce the release of a groundbreaking set of ontologies designed to enhance data interoperability and analytics capabilities across the biopharmaceutical industry. These ontologies are the result of a collaborative effort within OAGi’s Industrial Ontologies Foundry (IOF) among domain experts, standards developers, and leading organizations. They establish a semantic foundation for consistent data exchange, integration, and interpretation.

The newly released ontologies cover core biomanufacturing concepts, including process parameters, equipment, quality attributes, various types of recipes and their components, processing steps, and materials. They are intended to serve as a common reference framework for systems integration, data analytics, regulatory submissions, and digital transformation initiatives across the biopharmaceutical manufacturing value chain.

“Ontologies give us a shared language to structure and contextualize manufacturing data. With this release, we’re one step closer to seamless interoperability across our systems, suppliers, and regulators. With this release, we see growing progress toward cross-consortia collaboration to create an interoperable ontology to serve the biopharmaceutical manufacturing industry,” said Roger Hart, NIIMBL Senior Fellow and Big Data Program Lead.